Related Experiment Video

Updated: May 31, 2026

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution

Published on: April 16, 2019

ANTICIPATE-ing a future without liver biopsy in MASH. Ready for prime time?

Harendran Elangovan1, Jacob George1

  • 1Storr Liver Centre, The Westmead Institute for Medical Research, Westmead Hospital and The University of Sydney, NSW, Australia.

JHEP Reports : Innovation in Hepatology
|May 28, 2026
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...